Drugmaker Aegerion’s Chapter 11 plan confirmed in New York
Aegerion's Chapter 11 plan was confirmed on 10 September. (Credit: iStock.com/AlexRaths)
Bankrupt US drugmaker Aegerion’s Chapter 11 plan, which envisages it sold to European rival Amryt Pharma, has been confirmed by a New York bankruptcy court.
To read more
Subscribe to Global Restructuring Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Restructuring Review experts.
Subscribe now